Pharmaceuticals 2013, 6(7), 851-866; doi:10.3390/ph6070851

Role of Diuretics and Ultrafiltration in Congestive Heart Failure

, ,  and * email
Received: 21 March 2013; in revised form: 21 May 2013 / Accepted: 14 June 2013 / Published: 4 July 2013
(This article belongs to the Special Issue Diuretics)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Volume overload in heart failure (HF) results from neurohumoral activation causing renal sodium and water retention secondary to arterial underfilling. Volume overload not only causes signs and symptoms of congestion, but can impact myocardial remodeling and HF progression. Thus, treating congestion is a cornerstone of HF management. Loop diuretics are the most commonly used drugs in this setting. However, up to 30% of the patients with decompensated HF present with loop-diuretic resistance. A universally accepted definition of loop diuretic resistance, however, is lacking. Several approaches to treat diuretic-resistant HF are available, including addition of distal acting thiazide diuretics, natriuretic doses of mineralocorticoid receptor antagonists (MRAs), or vasoactive drugs. Slow continuous veno-venous ultrafiltration is another option. Ultrafiltration, if it is started early in the course of HF decompensation, may result in prominent decongestion and a reduction in re-hospitalization. On the other hand, ultrafiltration in HF patients with worsening renal function and volume overload after aggressive treatment with loop diuretics, failed to show benefit compared to a stepwise pharmacological approach, including diuretics and vasoactive drugs. Early detection of congested HF patients for ultrafiltration treatment might improve decongestion and reduce readmission. However, the best patient characteristics and best timing of ultrafiltration requires further evaluation in randomized controlled studies.
Keywords: cardiac failure; diuretic resistance; diuretic combinations; ultrafiltration
PDF Full-text Download PDF Full-Text [476 KB, Updated Version, uploaded 5 July 2013 16:54 CEST]
The original version is still available [474 KB, uploaded 4 July 2013 14:22 CEST]

Export to BibTeX |

MDPI and ACS Style

Shchekochikhin, D.; Al Ammary, F.; Lindenfeld, J.A.; Schrier, R. Role of Diuretics and Ultrafiltration in Congestive Heart Failure. Pharmaceuticals 2013, 6, 851-866.

AMA Style

Shchekochikhin D, Al Ammary F, Lindenfeld JA, Schrier R. Role of Diuretics and Ultrafiltration in Congestive Heart Failure. Pharmaceuticals. 2013; 6(7):851-866.

Chicago/Turabian Style

Shchekochikhin, Dmitry; Al Ammary, Fawaz; Lindenfeld, Jo Ann; Schrier, Robert. 2013. "Role of Diuretics and Ultrafiltration in Congestive Heart Failure." Pharmaceuticals 6, no. 7: 851-866.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert